[Urticaria-vasculitis syndrome in metastatic malignant testicular teratoma].
We report on the case history of a 30-year-old man with chronic, therapy-resistant urticarial vasculitis for more than 1 year. On clinical examination a metastasizing malignant teratoma of the testes was diagnosed. For surgical management and oncological therapy the patient was referred to appropriate clinical units. After the treatment there urticarial vasculitis also disappeared without any specific therapy, but the persisting metastases in the lungs caused early reappearance of the urticarial vasculitis. Chemotherapy led to partial remission of metastases, and in fact also to an improvement in the urticarial alterations of the skin. Two months after the last cycle of chemotherapy metastases of the brain were discovered and at the same time the urticarial vasculitis was found to be present again in full-blown form.
Sprossmann
A
A
Dermatologische Klinik, Klinikum Lippe-Lemgo.
Müller
R P
RP
D000328:Adult; D000818:Animals; D014408:Biomarkers, Tumor / Q000097:blood; D001932:Brain Neoplasms / Q000175:diagnosis / Q000556:secondary; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000556:secondary; D008297:Male; D010257:Paraneoplastic Syndromes / Q000209:etiology* / Q000473:pathology; D012008:Recurrence; D012867:Skin / Q000098:blood supply*; D013724:Teratoma / Q000150:complications* / Q000175:diagnosis / Q000473:pathology / Q000556:secondary; D013736:Testicular Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000473:pathology; D014581:Urticaria / Q000209:etiology* / Q000473:pathology; D014657:Vasculitis / Q000209:etiology* / Q000473:pathology
D014408:Biomarkers, Tumor
Urtikaria-Vaskulitis-Syndrom beim metastasierenden malignen Hodenteratom.